https://medicalxpress.com/urology-news/ en-us Latest medical news and research in Urology A cross-disciplinary research team led by Hongjie Dai, director of the Materials Institute of Life Sciences and Energy (MILES) at the University of Hong Kong (HKU) in Shenzhen, has developed a promising near-infrared (NIR) fluorescent dye for potential clinical use in ureter imaging during surgical navigation. https://medicalxpress.com/news/2026-07-ureters-stay-visible-hours-dye.html Mon, 13 Jul 2026 11:20:07 EDT news703154731 A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research published in the July issue of The Journal of Nuclear Medicine. Findings from the repeat PSMA scans, which included both local and distant disease, resulted in a change in management for nearly 50% of these patients. https://medicalxpress.com/news/2026-07-prostate-specific-membrane-antigen-pet.html Sat, 11 Jul 2026 10:00:04 EDT news702823706 In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate cancer cases in patients of European ancestry have a gene rearrangement in which the genes TMPRSS2 and ERG are fused together. This causes the ERG protein to be turned on, increasing the growth and migration of tumor cells. However, ERG has been considered undruggable because it lacks the usual pockets that a drug can bind to. https://medicalxpress.com/news/2026-07-hidden-pocket-reveals-prostate-cancer.html Thu, 09 Jul 2026 15:20:01 EDT news702823022 A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a study conducted by researchers at Umeå University together with international collaborators, published in the journal Signal Transduction and Targeted Therapy. https://medicalxpress.com/news/2026-07-drug-metastatic-prostate-cancer-human.html Tue, 07 Jul 2026 21:40:04 EDT news702638917 One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including frequent urination, difficulty starting urination, nocturia and a weak urine stream. Although these are common symptoms, in older men they can significantly affect quality of life. https://medicalxpress.com/news/2026-07-older-men-reassess-term-prostate.html Tue, 07 Jul 2026 14:40:06 EDT news702646261 New research presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) suggests that exposure to air pollution may affect genes associated with sperm development, raising new questions about male fertility, pregnancy outcomes and offspring health. The study was published in Human Reproduction. https://medicalxpress.com/news/2026-07-air-pollution-sperm-genes-function.html Mon, 06 Jul 2026 19:00:05 EDT news702539391 A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could dramatically reduce overtreatment and encourage more men to get screened, potentially leading to significantly fewer deaths from aggressive prostate cancer. https://medicalxpress.com/news/2026-07-lowest-prostate-cancer.html Wed, 01 Jul 2026 16:00:11 EDT news702131221 The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million American men, with another 330,000 men expected to be diagnosed with the condition this year alone. https://medicalxpress.com/news/2026-07-dna-methylation-patterns-prostate-cancers.html Wed, 01 Jul 2026 07:40:02 EDT news702101821 Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The study, published in the Journal of Experimental Medicine (JEM), demonstrates that direct delivery of these CAR T cells via a catheter can control bladder tumors in mice, raising hopes that a similar approach may be effective in humans. https://medicalxpress.com/news/2026-06-intravesical-car-therapy-door-bladder.html Fri, 26 Jun 2026 10:00:06 EDT news701596381 Researchers from the EHU-University of the Basque Country have developed a robust protocol to detect the molecules involved in the metabolic reactions of sperm. The new method enables a detailed analysis even with small samples and allows the detection of the largest number of potential biomarkers identified to date; this advance could help diagnose male infertility and develop future clinical solutions. The paper is published in the journal Cells. https://medicalxpress.com/news/2026-06-methodology-biomarkers-male-infertility.html Thu, 25 Jun 2026 11:20:01 EDT news701603238 A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant cancer cases than the PSA test, without subjecting more men to unnecessary testing. The study is published in the Annals of Internal Medicine. https://medicalxpress.com/news/2026-06-blood-high-prostate-cancer-cases.html Tue, 23 Jun 2026 12:00:01 EDT news701432549 Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression. https://medicalxpress.com/news/2026-06-hidden-pim1-pathway-prostate-cancer.html Tue, 16 Jun 2026 15:20:03 EDT news700838188 Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing antitumor immunity, according to a preclinical study led by investigators at Weill Cornell Medicine and the Cornell Duffield College of Engineering. https://medicalxpress.com/news/2026-06-experimental-treatment-prostate-tumor-cells.html Mon, 15 Jun 2026 10:00:10 EDT news700735501 Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival for patients with intermediate- or high-risk localized prostate cancer. The study was led by researchers at the Johns Hopkins University School of Medicine, Johns Hopkins Kimmel Cancer Center, Department of Radiation Oncology and Molecular Radiation Sciences, and Brady Urological Institute. Findings from the study were published June 1 in The Lancet Oncology. https://medicalxpress.com/news/2026-06-immunotherapy-added-therapy-boosts-survival.html Tue, 02 Jun 2026 16:40:05 EDT news699629521